A Comparative Study of Aleglitazar and Actos in Patients With Type 2 Diabetes Mellitus and New York Heart Association (NYHA) Class II Heart Failure.

Name: A Comparative Study of Aleglitazar and Actos in Patients With Type 2 Diabetes Mellitus and New York Heart Association (NYHA) Class II Heart Failure.
License: Public Domain

Hoffmann-La Roche

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

diabetes mellitus type 2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 158124
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.